NCT01702506 Evaluation Of The Potential Effect That The Administration Of Food Or Antacid Medication May Have In The Oral Absorption Of Dacomitinib (PF-00299804) Status COMPLETED Phase PHASE1
NCT01701375 A Phase 1 Trial of TST of PD 0332991 Followed by Cytarabine and Mitoxantrone for Adults With Relapsed and Refractory Acute Leukemias and High-Risk Myelodysplasia Status TERMINATED Phase PHASE1
NCT01696071 Comparison of Two Daily Dose Regimens of Tiotropium 5 µg Once Daily and Tiotropium 2.5 µg Twice Daily for 4 Weeks on Top of Maintenance Therapy With Inhaled Corticosteroid Controller Medication Status COMPLETED Phase PHASE2
NCT01695499 Diagnostic Study of Biomarkers in BAL of ICU Patients With Lung Infiltrates Status UNKNOWN Phase N/A
NCT01693822 A Phase II Study of Axitinib in Patients With Metastatic Renal Cell Cancer Unsuitable for Nephrectomy Status COMPLETED Phase PHASE2
NCT01693445 S-1, Oxaliplatin, and Irinotecan for Advanced Gastrointestinal Cancer Status COMPLETED Phase PHASE1
NCT01692899 Retention Rates of Adalimumab, Etanercept and Infliximab as First and Second-Line Biotherapy in Patients With Rheumatoid Arthritis in Daily Practice Status COMPLETED Phase N/A
NCT01692886 A Study Evaluating 13-Valent Pneumococcal Conjugate Vaccine (13vPnC) In Healthy Infants In China Status COMPLETED Phase PHASE3
NCT01691274 A Study In Healthy People To Evaluate Safety, Toleration And Time Course Of Plasma Concentration Of Multiple Oral Doses Of PF-04895162 Status COMPLETED Phase PHASE1
NCT01691014 Formation of Antibodies and Subsequent Prediction of Clinical Response in Patients With Rheumatoid Arthritis Treated With Four TNF Blocking Agents Status TERMINATED Phase N/A
NCT01690351 A Study Comparing PF-05089771 TS Capsule To PF-05089771 TS Oral Dispersion In The Fasted State Status COMPLETED Phase PHASE1
NCT01689207 To Investigate the Safety and Tolerability of Aztreonam-Avibactam (ATM-AVI) Status COMPLETED Phase PHASE1
NCT01687673 Phase II Combination of Temsirolimus and Sorafenib in Advanced Hepatocellular Carcinoma Status COMPLETED Phase PHASE2
NCT01684215 A Study Of Oral Palbociclib (PD-0332991), A CDK4/6 Inhibitor, As Single Agent In Japanese Patients With Advanced Solid Tumors Or In Combination With Letrozole For The First-Line Treatment Of Postmenopausal Japanese Patients With ER (+) HER2 (-) Advanced Breast Cancer Status COMPLETED Phase PHASE2
NCT01680458 Diflucan Research For Infant Evaluation Of Antifungal Treatment And Prophylaxis Medication Status COMPLETED Phase N/A
NCT01679119 Treatment of Patients With Diffuse Large B Cell Lymphoma Who Are Not Suitable for Anthracycline Containing Chemotherapy Status COMPLETED Phase PHASE2
NCT01677065 A Randomized, Two-way, Crossover Study to Estimate the Relative Bioavailability of a Controlled-release Formulation of Oxycodone (40 mg) With Sequestered Naltrexone Compared With Immediate-release Oxycodone Tablets (20 mg) in Healthy Volunteers Status COMPLETED Phase N/A